Candriam Equities L Biotech.C EUR/ LU1120766388 /
NAV2024-03-27 | Chg.+2.9000 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
223.2200EUR | +1.32% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2015 | - | - | - | - | - | -0.99 | 5.05 | -12.19 | -11.06 | 8.94 | 8.18 | -2.47 | - |
2016 | -22.94 | -4.98 | -1.15 | 3.16 | 8.63 | -8.23 | 11.81 | -2.00 | 3.03 | -10.54 | 12.73 | -2.27 | -17.18% |
2017 | 2.97 | 8.66 | -0.57 | -0.74 | -6.02 | 7.82 | -0.95 | 5.93 | 1.46 | -5.24 | -2.17 | 0.73 | +11.22% |
2018 | 2.84 | -2.57 | -2.96 | -1.49 | 8.26 | 0.77 | 4.17 | 4.70 | -1.93 | -11.86 | 4.19 | -9.20 | -6.81% |
2019 | 12.70 | 4.36 | 0.82 | -4.77 | -3.93 | 7.06 | 0.91 | - | - | - | - | - | - |
2021 | - | - | - | - | - | - | 31.91 | 4.35 | -2.47 | 0.30 | -1.70 | 1.34 | - |
2022 | -9.30 | -1.76 | 7.03 | -2.16 | -5.45 | 6.05 | 7.35 | 2.94 | 0.68 | 5.55 | 1.91 | -6.30 | +4.91% |
2023 | 1.12 | -3.40 | -2.17 | 0.63 | 2.56 | -0.90 | -1.63 | 1.34 | -2.10 | -5.97 | 2.83 | 12.21 | +3.49% |
2024 | 3.19 | 1.72 | 0.26 | - | - | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 16.38% | 18.33% | 16.13% | 21.63% | 21.58% |
Sharpe ratio | 1.26 | 1.31 | 0.71 | - | 0.25 |
Best month | +12.21% | +12.21% | +12.21% | +12.21% | +31.91% |
Worst month | +0.26% | -5.97% | -5.97% | -9.30% | -9.30% |
Maximum loss | -5.34% | -8.69% | -14.01% | -19.84% | -19.84% |
Outperformance | -3.05% | - | -1.13% | +0.44% | - |
All quotes in EUR
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Candriam Equities L Biotech.V US... | reinvestment | 2,079.8999 | +16.10% | +14.33% | |
Candriam Equities L Biotech.C EU... | reinvestment | 223.2200 | +15.38% | - | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,088.9299 | +13.38% | +6.42% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,242.2400 | +15.59% | +23.90% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,455.9900 | +12.71% | +22.95% | |
Candriam Equities L Biotech.R GB... | reinvestment | 363.6200 | +13.59% | +27.14% | |
Candriam Equities L Biotech.R EU... | reinvestment | 328.9000 | +16.46% | +26.76% | |
Candriam Equities L Biotech.R CH... | reinvestment | 204.8800 | +11.72% | +5.39% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,865.6000 | +17.18% | +17.47% | |
Candriam Equities L Biotech.N-H ... | reinvestment | 151.9100 | - | - | |
Candriam Equities L Biotech.V US... | reinvestment | 607.9500 | +15.44% | +12.33% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,691.0000 | +15.96% | +13.91% | |
Candriam Equities L Biotech.C EU... | reinvestment | 200.5700 | +14.03% | +6.23% | |
Candriam Equities L Biotech.R US... | reinvestment | 270.5100 | +16.88% | +16.59% | |
Candriam Equities L Biotech.R EU... | reinvestment | 208.8800 | +14.35% | +8.84% | |
Candriam Equities L Biotech.C US... | reinvestment | 852.9000 | +15.86% | +13.77% | |
Candriam Equities L Biotech.C US... | paying dividend | 783.5000 | +15.82% | +13.66% |
Performance
YTD | +5.24% | ||
---|---|---|---|
6 Months | +12.99% | ||
1 Year | +15.38% | ||
3 Years | - | ||
5 Years | +55.74% | ||
Since start | +48.81% | ||
Year | |||
2023 | +3.49% | ||
2022 | +4.91% | ||
2018 | -6.81% | ||
2017 | +11.22% | ||
2016 | -17.18% |